Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="370507"/>
<meta>
<versionId value="22"/>
<lastUpdated value="2025-08-15T10:32:26.138Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 370507</b></p><a name="370507"> </a><a name="hc370507"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 22; Last updated: 2025-08-15 10:32:26+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-variable-definition.html">VariableDefinition</a></p></div><p><b>EvidenceVariableHandlingDetail</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 evidence-variable-handling-not-specified}">Evidence variable handling not specified</span></p><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/370507">https://fevir.net/resources/EvidenceVariable/370507</a></p><p><b>identifier</b>: FEvIR Object Identifier/370507, FEvIR Linking Identifier/NCT03640312-secondaryOutcome-3-12-weeks-</p><p><b>name</b>: Proportion_of_Patients_With_Hypertension_Control_at_6_and_12_weeks_12_weeks_at_NCT03640312</p><p><b>title</b>: Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312)</p><p><b>citeAs</b>: </p><div><p>Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 370507. Revised 2025-08-15. Available at: https://fevir.net/resources/EvidenceVariable/370507. Computable resource at: https://fevir.net/resources/EvidenceVariable/370507#json.</p>
</div><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="#hc370507/variable-definition">Group: membership = conceptual; combinationMethod = all-of</a></td></tr></table><p><b>handling</b>: extension</p><p><b>classifier</b>: <span title="Codes:">Outcome Measure</span>, <span title="Codes:">Secondary</span></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Group #variable-definition</b></p><a name="370507/variable-definition"> </a><a name="hc370507/variable-definition"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-conceptual-cohort-definition.html">ConceptualCohortDefinition</a></p></div><p><b>membership</b>: Conceptual</p><p><b>combinationMethod</b>: All of</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">defined by Reference</span></p><p><b>value</b>: <a href="EvidenceVariable-367886.html">Proportion of Patients With Hypertension Control at 6 and 12 weeks (NCT03640312)</a></p><p><b>exclude</b>: false</p><h3>Timings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>6 and 12 weeks</td></tr></table></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes:">defined by CodeableConcept</span></p><p><b>value</b>: <span title="Codes:">12 weeks</span></p><p><b>exclude</b>: false</p></blockquote></blockquote></div>
</text>
<contained>
<Group>
<id value="variable-definition"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"/>
</meta>
<membership value="conceptual"/>
<combinationMethod value="all-of"/>
<characteristic>
<code>
<text value="defined by Reference"/>
</code>
<valueReference>🔗
<reference value="EvidenceVariable/367886"/>
<type value="EvidenceVariable"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="NCT03640312-secondaryOutcome-3"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display
value="Proportion of Patients With Hypertension Control at 6 and 12 weeks (NCT03640312)"/>
</valueReference>
<exclude value="false"/>
<timing>
<text value="6 and 12 weeks"/>
</timing>
</characteristic>
<characteristic>
<code>
<text value="defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="12 weeks"/>
</valueCodeableConcept>
<exclude value="false"/>
</characteristic>
</Group>
</contained>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail">
<valueCodeableConcept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-variable-handling-not-specified"/>
<display value="Evidence variable handling not specified"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/EvidenceVariable/370507"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="370507"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="NCT03640312-secondaryOutcome-3-12-weeks-"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name
value="Proportion_of_Patients_With_Hypertension_Control_at_6_and_12_weeks_12_weeks_at_NCT03640312"/>
<title
value="Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312)"/>
<citeAs
value="Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 370507. Revised 2025-08-15. Available at: https://fevir.net/resources/EvidenceVariable/370507. Computable resource at: https://fevir.net/resources/EvidenceVariable/370507#json."/>
<status value="active"/>
<author>
<name
value="Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"/>
</author>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<definition>
<reference>
<reference value="#variable-definition"/>
<type value="Group"/>
</reference>
</definition>
<handling value="extension"/>
<classifier>
<text value="Outcome Measure"/>
</classifier>
<classifier>
<text value="Secondary"/>
</classifier>
</EvidenceVariable>